The previous press release was issued at 14:00 CET and has been updated to correct a typo. No other changes have been made to the original release.

The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee, along with the Chairman of the Board. The nominating committee shall be appointed during the fourth quarter based on the shareholding at the end of the third quarter.

At the end of the third quarter 2025, the three largest shareholders in Stille were Impilo AB, Linc AB and Lannebo Kapitalförvaltning. They have appointed the following representatives:

• Fredrik Strömholm, on behalf of Impilo AB
• Thomas Bergh, on behalf of Linc AB
• Adam Hansson, on behalf of Lannebo Kapitalförvaltning

The tasks of the nominating committee shall include proposing to the annual general meeting the election of the board and chairman of the board, if applicable, the election of the auditor, remuneration for the board and auditor, proposals regarding the chairman of the general meeting, and proposals on how the nominating committee should be appointed.

Contact Details
Ulrik Berthelsen
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se

About Us
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.

Attachments
Nominating Committee for the Annual General Meeting 2026 in Stille

Läs mer på MFN